![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1524245
Åõ¼® ¼ºñ½º ½ÃÀå : À¯Çüº°, ¼ºñ½ºº°, ÃÖÁ¾ ¿ëµµº° - ¿¹Ãø(2024-2032³â)Dialysis Services Market - By Type (Hemodialysis, Peritoneal Dialysis), By Service (Acute Dialysis, Chronic Dialysis), By End-use (In-center Dialysis, Home Dialysis) & Forecast, 2024 - 2032 |
¼¼°è Åõ¼® ¼ºñ½º ½ÃÀåÀº 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 5.1% ÀÌ»óÀÇ CAGRÀ» ±â·ÏÇÒ Àü¸ÁÀÔ´Ï´Ù.
¹Ì±¹ ±¹¸³´ç´¢º´¼Òȱâ½ÅÀ庴¿¬±¸¼Ò(National Institute of Diabetes and Digestive and Kidney Diseases NIDDKD)ÀÇ Ãֽе¥ÀÌÅÍ¿¡ µû¸£¸é, 2021³â ¹Ì±¹¿¡¼ ¾à 786,000¸íÀÌ ¸»±â½ÅºÎÀü(End-Stage Renal Disease ESRD)·Î Áø´Ü¹Þ°í, 71%°¡ Åõ¼® Ä¡·á¸¦ ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
CKD ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Åõ¼® ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿äµµ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¸»±â ½ÅºÎÀüÁõ ESRD ¹× ±âŸ ½ÅÀå °ü·Ã ÇÕº´ÁõÀ» ¾Î°í Àִ ȯÀÚµéÀÇ »ý¸í À¯Áö Ä¡·áÀÇ Çʿ伺¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ ¼ö¿ä¿¡ ´ëÀÀÇϱⰡ Á¡Á¡ ´õ ¾î·Á¿öÁö°í ÀÖÀ¸¸ç, Á¤±âÀûÀ̰í Àü¹®ÀûÀÎ Ä¡·á¸¦ ÇÊ¿ä·Î Çϴ ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Åõ¼® ±â¼ú°ú ¼ºñ½º Á¦°ø ¸ðµ¨ÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.
º¹¸· Åõ¼® ºÐ¾ß´Â 2024³â¿¡¼ 2032³â°£¿¡ µÎµå·¯Áø CAGRÀ» À¯ÁöÇÒ °ÍÀÔ´Ï´Ù. º¹¸· Åõ¼® ºÐ¾ß´Â Áý¿¡¼ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ¾î ȯÀÚÀÇ ÀÚÀ¯µµ°¡ ³ô°í ÀæÀº º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙ¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ÆíÀǼºÀº Àü ¼¼°è °Ç° ¹®Á¦¿¡¼ ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ ¹ßÀüÀ¸·Î º¹¸·Åõ¼®ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾î ´õ ¸¹Àº ȯÀڵ鿡°Ô ÀûÇÕÇÑ ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. º¹¸· Åõ¼®ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÇ·á ±â°üÀÌ ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» ¸ð»öÇÔ¿¡ µû¶ó º¹¸· Åõ¼®Àº ¸¸¼º ½ÅÀå Áúȯ °ü¸®¿¡¼ ±âÁ¸ Ç÷¾× Åõ¼®À» ´ëüÇÒ ¼ö ÀÖ´Â ¹Ù¶÷Á÷ÇÑ ´ë¾ÈÀ¸·Î ¿©°ÜÁö°í ÀÖ½À´Ï´Ù.
2032³â±îÁö ±Þ¼º Åõ¼® ºÐ¾ß°¡ Åõ¼® ¼ºñ½º ½ÃÀå¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀÔ´Ï´Ù. ±Þ¼º Åõ¼® ºÐ¾ß´Â ½É°¢ÇÑ °¨¿°, ¼ö¼ú ¹× ½É°¢ÇÑ Áúº´À¸·Î ÀÎÇÑ ±Þ¼º ½ÅÀå ¼Õ»ó(AKI)ÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ¼º Åõ¼® ºÐ¾ß°¡ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÔ¿ø ȯÀÚ ¼ö Áõ°¡¿Í ÁßȯÀڽǿ¡¼ÀÇ Áï°¢ÀûÀÎ ½ÅÀå ±â´É Áö¿øÀÇ Çʿ伺ÀÌ ±Þ¼º Åõ¼®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±Þ¼º Åõ¼® ±â¼úÀÇ ¹ßÀü°ú ȯÀÚ °á°úÀÇ °³¼±À¸·Î ÀÎÇØ ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü°¡ ÀÌ·¯ÇÑ Ä¡·á¸¦ ´õ ³Î¸® äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ±Þ¼º Åõ¼® ºÐ¾ß´Â ±ä±ÞÇÑ ÀÇ·á ¼ö¿ä¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Åõ¼® ½ÃÀåÀº ¸¸¼ºÄáÆÏº´(CKD) ¹× ´ç´¢º´ Àα¸ÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ 2032³â±îÁö ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀÔ´Ï´Ù. °æÁ¦ ¹ßÀü°ú µµ½ÃÈ´Â CKDÀÇ À§Çè ¿äÀÎÀ» Áõ°¡½ÃŰ´Â ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ÀÎÇÁ¶ó °³¼±°ú ½ÅÀå Ä¡·á °È¸¦ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀ¸·Î Åõ¼® ¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ½ÅÀå °Ç°¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÷´Ü ÀÇ·á±â¼úÀÇ °¡¿ë¼ºÀÌ ³ô¾ÆÁö¸é¼ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Åõ¼® ¼ºñ½º »ê¾÷ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Global Dialysis Services Market will witness over 5.1% CAGR from 2024 to 2032, driven by the escalating prevalence of chronic kidney diseases CKD, a trend amplified by aging populations and lifestyle-related illnesses. According to recent data from the National Institute of Diabetes and Digestive and Kidney Diseases NIDDKD, in 2021, about 786,000 individuals in the United States were diagnosed with End-Stage Renal Disease ESRD, with 71% undergoing dialysis treatment.
As CKD incidence rises, the demand for dialysis services surges correspondingly. This growth is propelled by the need for life-sustaining treatments among patients experiencing End-Stage Renal Disease ESRD and other kidney-related complications. Healthcare systems are increasingly challenged to meet this demand, prompting continuous advancements in dialysis technologies and service delivery models to cater to a growing patient population requiring regular and specialized care.
The overall dialysis services market is classified based on type, service, end-use, and region.
The peritoneal dialysis segment will maintain a notable CAGR between 2024 and 2032. The peritoneal dialysis sector offers patients more flexibility by allowing treatments to be performed at home, reducing the need for frequent hospital visits. This convenience is especially appealing amidst global health challenges. Additionally, advancements in technology have improved the effectiveness and safety of peritoneal dialysis, making it a viable option for more patients. As awareness grows about its benefits and as healthcare systems seek cost-effective solutions, peritoneal dialysis is increasingly viewed as a preferable alternative to traditional hemodialysis for managing chronic kidney disease.
By 2032, the acute dialysis segment will secure a significant dialysis services market share. The acute dialysis segment is rising due to the increasing incidence of acute kidney injuries AKI caused by severe infections, surgeries, and critical illnesses. The growing number of hospitalizations and the need for immediate renal support in intensive care units are driving the demand for acute dialysis. Additionally, advancements in acute dialysis techniques and improved patient outcomes are encouraging healthcare providers to adopt these treatments more widely. The acute dialysis segment is experiencing significant growth in response to urgent medical needs.
Asia Pacific dialysis services market will exhibit a significant CAGR through 2032 due to the rapid increase in the population with chronic kidney disease CKD and diabetes. Economic development and urbanization are contributing to lifestyle changes that heighten CKD risk factors. Additionally, improved healthcare infrastructure and government initiatives to enhance renal care make dialysis services more accessible. The rising awareness about kidney health and the availability of advanced medical technologies are catapulting the demand. These factors collectively contribute to the expanding dialysis services industry in Asia Pacific.